| |
Thursday, April 3, 2025 | 11am ET / 8am PT Join us for an insightful webinar on the latest advancements in cell and gene therapy, focusing on the innovative Cas9-CLIPT (Cleaved, Linearized with Protein Template) technology. Learn more about this groundbreaking technology designed to improve the efficiency of genome editing. Register now.
|
|
Today’s Big NewsMar 27, 2025 |
|
Wednesday, April 9, 2025 | 10am ET / 7am PT Learn the key steps for successfully entering Japan’s pharmaceutical market. This webinar covers regulatory requirements, compliance strategies, supply chain best practices, and common challenges. Gain expert insights to navigate this high-potential market with confidence. Don’t miss out—register now to secure your spot!
|
|
| By Gabrielle Masson The federal government is cutting 3,500 full-time FDA employees and 1,200 NIH workers as part of an overarching move designed to eliminate 10,000 jobs in the Department of Health and Human Services. |
|
|
|
By Zoey Becker A former Pfizer-turned-GSK scientist reportedly told colleagues that Pfizer delayed the results of its COVID-19 vaccine trials, prompting an investigation as GSK brought the matter to federal prosecutors shortly after the recent election. |
By Conor Hale According to the FDA’s public database, since the start of this year the agency has issued only two de novo clearances, far below its quarterly average. |
By Fraiser Kansteiner As President Donald Trump renewed his threat of potential pharmaceutical tariffs this week, trade group the Biotechnology Innovation Organization is warning of the fallout the additional duties could have on patients’ access to medicines. |
|
Wednesday, April 9, 2025 | 11am ET / 8am PT Health systems around the globe face a difficult paradox: delivering more care with fewer resources. In this exclusive webinar, our expert panel will explore how AI-based solutions are addressing these challenges with real-world examples, experience, and published outcomes in ASCO and Nature. Register now.
|
|
By James Waldron Tara Schwetz, Ph.D., a deputy director at the National Institutes of Health and overseer of ARPA-H's creation, has reportedly been put on administrative leave in the latest shake-up to the health agency’s leadership. |
By Andrea Park Eli Lilly is expanding its menu of direct-to-consumer healthcare offerings. The Big Pharma announced Thursday that its LillyDirect platform will now connect U.S. users to both in-person and virtual care options for Alzheimer’s disease. |
By Angus Liu Merck & Co.’s subcutaneous formulation of Keytruda has matched up to the original intravenous version on two blood concentration measurements, paving way for a potential FDA approval that could give patients a more convenient option of the widely used cancer drug. |
By James Waldron Nkarta is laying off a third of its employees, including half of the biotech’s executive leadership, as the company diverts cash to its lead CAR NK candidate. |
By Fraiser Kansteiner As part of an ongoing expansion strategy around the globe, Chiesi announced this week that it will invest 430 million euros (roughly $464 million) to build a new facility for inhalers and other health products in the Nerviano municipality of the Italian city of Milan, while also revitalizing a decades old production site there. |
By Darren Incorvaia Lyndra Therapeutics, which spun out of Moderna co-founder Robert Langer’s lab at the Massachusetts Institute of Technology in 2015, is winding down operations this week, a person with knowledge of the situation told Fierce Biotech. |
Fierce podcastsDon’t miss an episode |
| | This week on "The Top Line," we explore the potential impacts of this year's sizable patent cliff on the pharma industry at large. |
|
|---|
|
|
|
Thursday, April 10, 2025 | 11am ET / 8am PT Cell and gene therapies offer hope for previously untreatable diseases, with viral vectors currently favored as the primary gene delivery method. However, the complexities pose key challenges. In this webinar, learn how to choose the right production platform for achieving commercial timelines and managing manufacturing costs. Register now.
|
|
| WhitepaperRead about four trends that will shape the innovations, therapies, & market landscape in oncology during 2025 & beyond. Presented by Blue Matter, strategic consultants in the life sciences |
| WhitepaperDiscover how to revolutionize your vaccine trials with Avacare's latest white paper. Gain exclusive access to innovative, data-driven recruitment strategies that ensure diverse, efficient, and high-quality vaccine trials. Sponsored by: Avacare Clinical Research Network |
| WhitepaperDevelop your CAR molecule faster Sponsored by: Cell Signaling Technology |
| |
|
